Amylin Signaling in Diabetes and Alzheimer's Disease: Therapy or Pathology?

Journal of Neurology & Neuromedicine
doi 10.29245/2572.942x/2019/1.1212
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Sciaccess Publishers LLC

Related search

Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease

PLoS ONE
Multidisciplinary
2009English

Neurotrophin Regulation of Alzheimer's Disease Pathology

English

Increased Risk of Alzheimer's Disease in Type II Diabetes: Insulin Resistance of the Brain or Insulin-Induced Amyloid Pathology?: Figure 1

Biochemical Society Transactions
Biochemistry
2005English

Milder Alzheimer's Disease Pathology in Heart Failure and Atrial Fibrillation

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2017English

ER Stress in Alzheimer's Disease: A Novel Neuronal Trigger for Inflammation and Alzheimer's Pathology

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2009English

Emerging Pathways Driving Early Synaptic Pathology in Alzheimer's Disease

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2017English

Linking Type 2 Diabetes and Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Misfolded Proteins in Alzheimer's Disease and Type II Diabetes

Chemical Society Reviews
Chemistry
2012English

Imaging of Cerebrovascular Pathology in Animal Models of Alzheimer's Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy